Max Planck Institute of Experimental Medicine
Human behavior is the most amazing of all phenomena that life has brought forth. With apparent ease, the nervous system archives key experiences from the earliest days of childhood, controls extremely precise movements, reasons out solutions to complex mathematical problems and creates the consciousness that differentiates the species Homo sapiens from all other animals. However, as amazingly well constructed as this network of nerve cells - or neurons - is, the consequences are just as profound when it is damaged: brain injuries or degenerative diseases, or even the smallest defect in cell development can lead to massive brain cell loss, memory failure or breakdown of muscle control.
How can nerve cells be protected from such fatal degenerations and malfunctions? And how is it possible that such a gigantic system as the human brain functions at all - a system in which around 100 billion neurons are interconnected and more than 100 trillion synapses communicate with one another? These questions form the central focus of research at the Max Planck Institute of Experimental Medicine.
The institute was founded in 1947 as "Medical Research Institution". In 1948 it was taken over by the Max-Planck-Society and in 1965, it received its current name "Max Planck Institute of Experimental Medicine".
The research focus of the institute is on neuroscience. Research activities cover a wide spectrum of topics, ranging from basic molecular analyses of neuronal processes to clinical studies on novel therapies of neurological and psychiatric disorders in patients. The central aim of all these studies is to understand basic molecular and cellular processes in brain function, to analyze their pathological dysfunction in psychiatric and neurological diseases, and ultimately to develop novel therapies for these disorders.
Collaborate Research Center
- CRC 889: Cellular Mechanisms of Sensory Processing
GAUG, MPIEM, MPIDS, MPI BC, DPZ, UMG, ENI
The MPIEM is affiliated with the following research centers:
- Bernstein Focus Neurotechnology (BFNT) Göttingen
- Bernstein Center for Computational Neuroscience (BCCN) Göttingen
- Center for Systems Neuroscience (CSN)
- European Neuroscience Institute Göttingen (ENI-G)
- German Centre for Cardiovascular Research (DZHK), Göttingen
- Heart Research Center Göttingen (HRCG)
Graduate Study Programs
The MPIEM participates in the following graduate study programs:
- Georg August University School of Science (GAUSS)
- International Max Planck Research School: Molecular Biology
- International Max Planck Research School: Neurosciences
- International Max Planck Research School: Physics of Biological and Complex Systems
- Göttingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences
Possible treatment for Charcot-Marie-Tooth disease discovered
The dietary supplement Lecithin improves the myelination of diseased Schwann cells
Children and adolescents in high-risk environments more likely to become violent adults
Study provides first scientific hint that living in big cities, experiencing physical or sexual abuse, migration, cannabis...
Göttingen gets new International Max Planck Research School for Genome Science
In fall this year, the International Max Planck Research School (IMPRS) for Genome Science will start at the Göttingen...
Aberrant synapse protein can lead to neurological and psychiatric disorders
Scientists in Göttingen discover cause of brain disease